FREMONT, CA, Aug. 07, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC)... The post ABVC Corporate Update and CEO’s...
COMPASS Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, reported...
Tel Aviv, Israel / Vancouver, Canada, Aug. 01, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc.... The post Clearmind Medicine Files Patent Application...
The majority of participants reported significant improvements in their overall mental health The post Psilocybin-like drug may help people suffering...
Filament Health Corp. (OTCQB: FLHLF / NEO: FH / FSE: 7QS), a clinical-stage natural psychedelic drug development company, is pleased to announce an...
Source: Patrick Trucchio 07/19/2023 The firm continues advancing its lead drug candidates, including those for anxiety and treatment-resistant...
Filament Health Corp. (OTCQB: FLHLF / NEO: FH / FSE: 7QS), a clinical‐stage natural psychedelic drug development company, and Jupiter Acquisition...
The agreement would merge Filament with Jupiter Acquisition Corporation (NASDAQ: JAQC) The post Filament Health Heading to NASDAQ With SPAC Merger appeared...
PharmaTher Announces Positive Research Results for PharmaPatch™ with N,N-dimethyltryptamine (DMT) and Strategic Investment into Sairiyo Therapeutics The...
It is unclear whether Lightburn will transition as the head honcho of the new entity. The post Psychedelic Drug Developer Set for Nasdaq Listing in $210...